Aarti Pharmalabs Performance
- Today's Low
- ₹698
- Today's High
- ₹720
- 52 Week Low
- ₹585
- 52 Week High
- ₹970
- Open Price₹717
- Previous Close₹717
- Volume108,849
- 50 DMA₹690.20
- 100 DMA₹698.30
- 200 DMA₹719.20
Aarti Pharmalabs Chart
Investment Returns
- Over 1 Month + 9.21%
- Over 3 Month + 1.45%
- Over 6 Month -11.84%
- Over 1 Year -26.1%
Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!
Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.4
- PEG Ratio
- -1.1
- Market Cap Cr
- 6,419
- P/B Ratio
- 3
- Average True Range
- 23.4
- EPS
- 20.6
- Dividend Yield
- 0.6
- MACD Signal
- 10.8
- RSI
- 55.02
- MFI
- 67.77
Latest Stock News Updates
Please find enclosed
- BSE India
- 1 week 3 days ago
Please find enclosed
- BSE India
- 2 weeks 3 days ago
Please find enclosed
- BSE India
- 3 weeks 2 days ago
Aarti Pharmalabs Financials
Aarti Pharmalabs Technicals
EMA & SMA
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹698.20
- 50 Day
- ₹690.20
- 100 Day
- ₹698.30
- 200 Day
- ₹719.20
Resistance and Support
- R3 741.20
- R2 730.60
- R1 719.20
- S1 697.30
- S2 686.70
- S3 675.40
Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends
About Aarti Pharmalabs
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India. View More- NSE Symbol
- AARTIPHARM
- BSE Symbol
- 543748
- ISIN
- INE0LRU01027
Similar Stocks to Aarti Pharmalabs
Popular Stocks
Aarti Pharmalabs FAQs
Aarti Pharmalabs share price is ₹707 As on 18 July, 2026 | 08:43
The Market Cap of Aarti Pharmalabs is ₹6419.2 Cr As on 18 July, 2026 | 08:43
The P/E ratio of Aarti Pharmalabs is 34.4 As on 18 July, 2026 | 08:43
The PB ratio of Aarti Pharmalabs is 3 As on 18 July, 2026 | 08:43
The 52 week High & Low of Aarti Pharmalabs is ₹969.5/₹585 respectively As on 18 July, 2026 | 08:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.